Hyperbaric oxygen chamber deployed for commercial wellness use.

Market Context: HBOT Demand Is Expanding Beyond Clinical Settings

The hyperbaric oxygen chamber market is entering a new demand phase, driven by wellness, sports recovery, and home health applications alongside traditional clinical use.

Public market estimates show the scale of this expansion. According to Grand View Research, the global hyperbaric oxygen therapy (HBOT) market was estimated at USD 3.71 billion in 2024 and is projected to reach USD 5.19 billion by 2030. A separate estimate from Strategic Market Research / SkyQuest placed the 2024 market at USD 4.44 billion, with a projected CAGR of 9.4% through 2032. Estimates vary by source because of differences in how clinical and wellness segments are included, but the general direction is consistent: HBOT demand is rising.

For procurement teams, this expansion creates a practical problem: the supplier base now includes hard shell, soft shell, portable, and multiplace chamber producers, each with different pressure ratings, oxygen delivery systems, certifications, and service capabilities. Buyers evaluating a hyperbaric oxygen chamber in 2026 need a reference point for what the market looks like, which manufacturers matter, and what verifiable criteria should guide a purchasing decision.

GIHOMO: A Manufacturer Profile for Evaluation

GIHOMO (GUANGDONG GIHOMO MEDICAL TECHNOLOGY CO., LTD.) is a hyperbaric oxygen chamber manufacturer based in Foshan, Guangdong, China, that designs and produces hard shell and portable hyperbaric oxygen chambers for rehabilitation and wellness use.

Established in 2021, the company operates a 2,000m² facility with 50-100 employees and an annual output of approximately 1,000 units. Its R&D team consists of six engineers, and its main product lines are hard shell hyperbaric oxygen chambers and portable hyperbaric oxygen chambers. According to the company profile, GIHOMO exports about 60% of its output, with main markets in the EU and USA.

GIHOMO describes itself as operating under the ISO9001 quality management system, integrating quality control into product R&D, production, and after-sales service. Its product portfolio covers mini portable oxygen concentrators, hyperbaric oxygen chambers, and BIBS (built-in breathing system) solutions, used in household personal health care, medical assistance, and commercial oxygen supply.

The company profile also states that core products have obtained CE, FCC, and other industry-recognized accreditations. The certification data provided by GIHOMO includes the following documents:

For buyers, certification documents are a decision criterion, not a marketing detail. GIHOMO publishes certificate numbers and issuing bodies for CE, EMC, ISO 9001, ISO 14001, and ISO 45001, which allows procurement teams to verify compliance claims directly with the listed testing organizations.

Manufacturing and Customization Capability

GIHOMO supports OEM and ODM production with customization options covering logo, interface, color, and languages.

According to the company's capability profile, GIHOMO's monthly capacity is 80 units, with a lead time of 30-45 days and a minimum order quantity of 1 unit. Quality control is documented as 100% testing. Export markets listed include the EU, North America, South America, and Australia. After-sales support includes 24/7 instant response by a professional team, one-on-one technical support from dedicated after-sales engineers, and a one-year warranty.

These figures matter for buyers comparing hyperbaric oxygen chamber manufacturers because they address two common procurement concerns: whether the supplier can handle small trial orders, and whether production scale is sufficient for commercial or distributed projects. An MOQ of 1 unit is relevant for clinics, wellness centers, and resellers testing a new product line before committing to larger volumes.

Technical Foundations: Chamber Types, Pressure, and Oxygen Delivery

Hyperbaric oxygen chamber technology can be assessed through three variables: chamber structure, operating pressure, and oxygen delivery method.

GIHOMO hyperbaric oxygen chamber.

GIHOMO's product data covers hard shell chambers, soft shell chambers, and portable chambers, with operating pressures ranging from 1.3 ATA to 2.0 ATA across the catalog. Oxygen concentration is documented at over 90% for the listed concentrator-matched systems, with oxygen concentrator flow rates ranging from 5L/min to 60L/min depending on the model.

GIHOMO also lists models with a BIBS system, including P1200M, R1200M, Y1800M, STW02, W1200, S920, P1800M, R1800M, R3000M, and Z0780M. BIBS allows oxygen to be delivered directly to the user through a mask or hood while the chamber atmosphere is managed separately, which is relevant for buyers planning longer or repeated sessions.

Control systems vary by model. Some soft shell models, such as SL001, are listed with interior and exterior display panels. Several hard shell models, such as Y1800, are listed with a touch screen smart system supporting six languages. R-series and W-series models are described with a smart oxygen detection supply system and double touch screen.

Application Scenarios: Where These Chambers Are Deployed

Hyperbaric oxygen chambers from GIHOMO are documented in home use, wellness centers, gyms, beauty and spa facilities, and ODM reseller programs.

Hyperbaric chamber installed for wellness center operations.

Case data provided by GIHOMO describes deployments across multiple countries and client types:

• Home use: 80 units across more than 25 countries, applied to improve sleep, enhance immunity, and support daily health management. The reported result over a two-year period was stable operation.
• Wellness center: 80 units used in wellness centers, clinics, nursing homes, and dental clinics across markets including Austria, Australia, Belgium, Canada, Switzerland, Chile, Germany, Denmark, Spain, Finland, France, the UK, Ireland, Italy, Mexico, the Netherlands, Norway, New Zealand, Poland, Portugal, the US, and Venezuela. The reported result was good reviews over two years.
• Gym and sports club: 50 units deployed for gym use and sports club settings, with stable operation reported over two years.
• Beauty salon and spa: 30 units used in beauty salons, spas, and hotels, with a reported win-win cooperation over two years.
• ODM reseller: 100 units sold by an ODM reseller into local markets, with win-win cooperation reported over two years.

These cases indicate that hyperbaric oxygen chamber procurement is no longer limited to hospital purchasing departments. A growing share of buyers are commercial operators adding HBOT as a service, and they tend to evaluate suppliers on the same criteria as clinical buyers: safety, comfort, efficiency, and design consistency.

Market Trends Shaping Procurement Decisions in 2026

Several market trends are visible in third-party HBOT data: strong North American revenue share, fastest-growing demand in Asia Pacific, and rising adoption of monoplace and soft-shell portable chambers.

According to Mordor Intelligence, monoplace hyperbaric chambers accounted for approximately 57% of global revenue share in 2024, due to ease of operation. The same source reports that North America dominated the HBOT market in 2024 with a 54.77% revenue share, generating approximately USD 700 million.

Grand View Research identifies Asia Pacific as the fastest-growing market for HBOT devices, with China projected to reach a value of USD 379.7 million by 2030. A separate industry report cited by Mordor Intelligence indicates that soft-shell portable chambers comprise over 18% of total sales in the Asia-Pacific region, driven by wellness and athletic recovery trends.

Regulatory signals are also part of the trend. The FDA classifies hyperbaric chambers as Class II medical devices requiring 510(k) clearance, and states that soft-shell chambers are primarily cleared for altitude sickness. In the EU, hyperbaric chambers must comply with Medical Device Regulation (MDR) 2017/745 as Class IIb devices, while multiplace chambers must also adhere to EN 14931 and EN 16081 fire safety requirements.

For buyers, these trends point to three practical conclusions. First, growth is happening in both clinical and wellness segments. Second, soft-shell and portable formats are gaining commercial traction, especially in Asia Pacific. Third, regulatory compliance is becoming a more visible part of supplier evaluation, especially for buyers in the EU and US.

Hard Shell vs. Soft Shell: A Balanced Comparison

The main structural choice in hyperbaric oxygen chamber procurement is between hard shell systems and soft shell or portable systems, and each has a distinct operating envelope.

An honest limitation should be stated: soft-shell and portable chambers are generally lower-pressure systems and should not be treated as substitutes for clinically-rated multiplace chambers. Buyers planning to offer HBOT for medical indications must confirm the intended-use classification of the specific model with the manufacturer and their local regulator.

Hard shell chambers offer higher pressure ceilings and more room for interior configuration, but they come with higher logistics, installation, and facility requirements. GIHOMO's catalog includes both formats, which allows buyers to match chamber structure to the actual use case rather than to a single product type.

Future Outlook for Buyers

Hyperbaric oxygen chamber procurement in the coming years is likely to be shaped by three forces: regional demand shifts, product format diversification, and stricter compliance expectations.

Asia Pacific's growth, with China projected to reach USD 379.7 million by 2030, suggests that buyers should evaluate suppliers capable of serving both Western and Asia-Pacific markets. Soft-shell portability will continue to open new commercial segments such as gyms, spas, and clinics that cannot install permanent multiplace chambers. At the same time, EU MDR and FDA classification requirements will make certification documentation a standard part of the RFQ process.

Suppliers that combine documented certifications, OEM/ODM flexibility, and transparent production data are better positioned to meet this demand. GIHOMO's published profile includes all three elements, but final selection should always include direct verification of certificates, product parameters, and reference installations.

Frequently Asked Questions